PAR PHARM FDA Approval ANDA 089145

ANDA 089145

PAR PHARM

FDA Drug Application

Application #089145

Application Sponsors

ANDA 089145PAR PHARM

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORALEQ 25MG HYDROCHLORIDE0HYDROXYZINE PAMOATEHYDROXYZINE PAMOATE

CDER Filings

PAR PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 89145
            [companyName] => PAR PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROXYZINE PAMOATE","activeIngredients":"HYDROXYZINE PAMOATE","strength":"EQ 25MG HYDROCHLORIDE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROXYZINE PAMOATE","submission":"HYDROXYZINE PAMOATE","actionType":"EQ 25MG HYDROCHLORIDE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.